Cue Biopharma, Inc. (CUE)
NASDAQ·Healthcare·Biotechnology
$19.90
+8.62%
Mkt Cap $200.93M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$4.33
Range $2.00 – $7.00
Implied Upside
-78.2%
Consensus $4.33 vs current $19.90
NASDAQ·Healthcare·Biotechnology
$19.90
+8.62%
Mkt Cap $200.93M
No recent rating data.
Price Target (4 analysts)
$4.33
Range $2.00 – $7.00
-78.2%
Consensus $4.33 vs current $19.90